328 related articles for article (PubMed ID: 23592955)
1. Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation.
Cohen Freue GV; Meredith A; Smith D; Bergman A; Sasaki M; Lam KK; Hollander Z; Opushneva N; Takhar M; Lin D; Wilson-McManus J; Balshaw R; Keown PA; Borchers CH; McManus B; Ng RT; McMaster WR;
PLoS Comput Biol; 2013 Apr; 9(4):e1002963. PubMed ID: 23592955
[TBL] [Abstract][Full Text] [Related]
2. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
Percy AJ; Yang J; Chambers AG; Mohammed Y; Miliotis T; Borchers CH
Adv Exp Med Biol; 2016; 919():515-530. PubMed ID: 27975233
[TBL] [Abstract][Full Text] [Related]
3. Qualification and Verification of Protein Biomarker Candidates.
Zhao Y; Brasier AR
Adv Exp Med Biol; 2016; 919():493-514. PubMed ID: 27975232
[TBL] [Abstract][Full Text] [Related]
4. Coherent pipeline for biomarker discovery using mass spectrometry and bioinformatics.
Al-Shahib A; Misra R; Ahmod N; Fang M; Shah H; Gharbia S
BMC Bioinformatics; 2010 Aug; 11():437. PubMed ID: 20796299
[TBL] [Abstract][Full Text] [Related]
5. A bioinformatics approach for biomarker identification in radiation-induced lung inflammation from limited proteomics data.
Oh JH; Craft JM; Townsend R; Deasy JO; Bradley JD; El Naqa I
J Proteome Res; 2011 Mar; 10(3):1406-15. PubMed ID: 21226504
[TBL] [Abstract][Full Text] [Related]
6. Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.
Boja ES; Fehniger TE; Baker MS; Marko-Varga G; Rodriguez H
J Proteome Res; 2014 Dec; 13(12):5325-32. PubMed ID: 25171765
[TBL] [Abstract][Full Text] [Related]
7. SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine.
Mermelekas G; Vlahou A; Zoidakis J
Expert Rev Mol Diagn; 2015; 15(11):1441-54. PubMed ID: 26472065
[TBL] [Abstract][Full Text] [Related]
8. Proteomic signatures in plasma during early acute renal allograft rejection.
Freue GV; Sasaki M; Meredith A; Günther OP; Bergman A; Takhar M; Mui A; Balshaw RF; Ng RT; Opushneva N; Hollander Z; Li G; Borchers CH; Wilson-McManus J; McManus BM; Keown PA; McMaster WR;
Mol Cell Proteomics; 2010 Sep; 9(9):1954-67. PubMed ID: 20501940
[TBL] [Abstract][Full Text] [Related]
9. A computational pipeline for the development of multi-marker bio-signature panels and ensemble classifiers.
Günther OP; Chen V; Freue GC; Balshaw RF; Tebbutt SJ; Hollander Z; Takhar M; McMaster WR; McManus BM; Keown PA; Ng RT
BMC Bioinformatics; 2012 Dec; 13():326. PubMed ID: 23216969
[TBL] [Abstract][Full Text] [Related]
10. Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry.
Yocum AK; Chinnaiyan AM
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):145-57. PubMed ID: 19279071
[TBL] [Abstract][Full Text] [Related]
11. Targeted mass spectrometry approaches for protein biomarker verification.
Meng Z; Veenstra TD
J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
13. Serum proteomics in multiple sclerosis disease progression.
Tremlett H; Dai DL; Hollander Z; Kapanen A; Aziz T; Wilson-McManus JE; Tebbutt SJ; Borchers CH; Oger J; Cohen Freue GV
J Proteomics; 2015 Apr; 118():2-11. PubMed ID: 25753122
[TBL] [Abstract][Full Text] [Related]
14. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
15. Targeted and Untargeted Proteomics Approaches in Biomarker Development.
Sobsey CA; Ibrahim S; Richard VR; Gaspar V; Mitsa G; Lacasse V; Zahedi RP; Batist G; Borchers CH
Proteomics; 2020 May; 20(9):e1900029. PubMed ID: 31729135
[TBL] [Abstract][Full Text] [Related]
16. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
[TBL] [Abstract][Full Text] [Related]
17. Revisiting biomarker discovery by plasma proteomics.
Geyer PE; Holdt LM; Teupser D; Mann M
Mol Syst Biol; 2017 Sep; 13(9):942. PubMed ID: 28951502
[TBL] [Abstract][Full Text] [Related]
18. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
Pan S; Chen R; Crispin DA; May D; Stevens T; McIntosh MW; Bronner MP; Ziogas A; Anton-Culver H; Brentnall TA
J Proteome Res; 2011 May; 10(5):2359-76. PubMed ID: 21443201
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Candidate Biomarkers.
Wiktorowicz JE; Soman KV
Adv Exp Med Biol; 2016; 919():443-462. PubMed ID: 27975230
[TBL] [Abstract][Full Text] [Related]
20. Multiple reaction monitoring (MRM) of plasma proteins in cardiovascular proteomics.
Dardé VM; Barderas MG; Vivanco F
Methods Mol Biol; 2013; 1000():191-9. PubMed ID: 23585093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
